BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Nov 15, 2025; 16(11): 110007
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.110007
Evolution of the risk concept and assessment tools for diabetes during Ramadan fasting: A narrative review
Salem A Beshyah
Salem A Beshyah, Department of Endocrinology, Bareen International Hospital, MBZ City MBZ1507, Abu Dhabi, United Arab Emirates
Author contributions: Beshyah SA performed the research, drafting, and revision of the whole manuscript.
Conflict-of-interest statement: The author has no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salem A Beshyah, PhD, Adjunct Professor, Consultant, MRCP, Department of Endocrinology, Bareen International Hospital, Jabal Sawda’a Street, MBZ City MBZ1507, Abu Dhabi, United Arab Emirates. beshyah@yahoo.com
Received: May 28, 2025
Revised: July 30, 2025
Accepted: September 25, 2025
Published online: November 15, 2025
Processing time: 170 Days and 18.6 Hours
Abstract
BACKGROUND

The categorization and assessment of diabetes-related risks during Ramadan have evolved significantly over three decades. Research interest in the health effects of fasting has grown significantly, with diabetes emerging as the most extensively studied condition.

AIM

To explore the historical development of risk stratification approaches for Ramadan fasting in people with diabetes, culminating in the 2021 International Diabetes Federation-Diabetes and Ramadan (IDF-DAR) risk assessment tool. We also evaluated the evidence for its validation and real-world utility.

METHODS

The PubMed and Google Scholar databases were searched using the term “Diabetes AND Ramadan AND Risk Assessment”. Eligible studies included full-text articles on risk stratification concept and tools for diabetes during Ramadan. Selected studies were reviewed and synthesized thematically.

RESULTS

Risk categorization began with a dichotomy and tripartite models and progressed to a four-tier narrative scale. In 2021, the IDF-DAR tool introduced a point-based system with three risk categories. Validation studies across diverse populations demonstrated strong predictive value, though moderate inter-clinician variability and potential overestimation in type 2 diabetes cases were noted.

CONCLUSION

The IDF-DAR risk stratification tool significantly advances individualized diabetes care during Ramadan. Its conservative bias in some populations and variability in physician scoring suggests the need for standardized training.

Keywords: Diabetes; Ramadan; Risk stratification; International diabetes federation-diabetes and Ramadan; Hypoglycemia; Hyperglycemia; Diabetic ketoacidosis

Core Tip: Risk assessment is a core value in the management of Muslims with diabetes during Ramadan fasting. The International Diabetes Federation-Diabetes and Ramadan risk stratification tool significantly advances individualized diabetes care during Ramadan. While generally effective, its conservative bias in certain populations and variability in physician scoring suggests the need for standardized training and further research.